Concepts (48)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical, Undergraduate | 3 | 2023 | 95 | 0.960 |
Why?
|
| Curriculum | 3 | 2023 | 318 | 0.740 |
Why?
|
| Students, Medical | 3 | 2023 | 158 | 0.610 |
Why?
|
| Anatomy | 3 | 2023 | 25 | 0.590 |
Why?
|
| Dissection | 2 | 2016 | 13 | 0.530 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 10 | 0.520 |
Why?
|
| Clenbuterol | 4 | 2003 | 11 | 0.320 |
Why?
|
| Adrenergic beta-Agonists | 4 | 2003 | 27 | 0.320 |
Why?
|
| Hindlimb Suspension | 3 | 2003 | 16 | 0.280 |
Why?
|
| Muscle, Skeletal | 3 | 2003 | 316 | 0.230 |
Why?
|
| Educational Measurement | 3 | 2016 | 102 | 0.220 |
Why?
|
| Clinical Clerkship | 1 | 2023 | 27 | 0.200 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 76 | 0.120 |
Why?
|
| Learning | 1 | 2016 | 161 | 0.110 |
Why?
|
| Faculty, Medical | 2 | 2011 | 74 | 0.100 |
Why?
|
| Computer-Assisted Instruction | 1 | 2006 | 26 | 0.060 |
Why?
|
| Spermidine | 2 | 2003 | 34 | 0.060 |
Why?
|
| Teaching | 1 | 2006 | 59 | 0.060 |
Why?
|
| Education, Medical | 1 | 2006 | 118 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2003 | 1766 | 0.050 |
Why?
|
| Internet | 1 | 2006 | 236 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2003 | 51 | 0.050 |
Why?
|
| Biogenic Polyamines | 1 | 2002 | 7 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2002 | 13 | 0.050 |
Why?
|
| Rats | 4 | 2003 | 3735 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2002 | 35 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 147 | 0.040 |
Why?
|
| Humans | 4 | 2023 | 43102 | 0.040 |
Why?
|
| Body Fluids | 1 | 2000 | 19 | 0.040 |
Why?
|
| Child | 1 | 2023 | 3443 | 0.030 |
Why?
|
| Animals | 4 | 2003 | 16992 | 0.020 |
Why?
|
| United States | 1 | 2023 | 5205 | 0.020 |
Why?
|
| Male | 4 | 2003 | 23409 | 0.020 |
Why?
|
| Data Collection | 1 | 2006 | 210 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2006 | 359 | 0.010 |
Why?
|
| Schools, Medical | 1 | 2006 | 208 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 36 | 0.010 |
Why?
|
| Epinephrine | 1 | 2003 | 36 | 0.010 |
Why?
|
| Nonlinear Dynamics | 1 | 2003 | 35 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2003 | 97 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2002 | 7 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2002 | 10 | 0.010 |
Why?
|
| Putrescine | 1 | 2002 | 27 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 114 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2000 | 83 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 712 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 611 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 1081 | 0.010 |
Why?
|